InsidersTradesSigma
Follow the ラクオリア創薬株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ラクオリア創薬株式会社 has logged 9 insider filings. Market capitalisation: €12.5bn. The latest transaction was disclosed on 29 January 2026 (Holding update). Among the most active insiders: HK inno.N Corporation. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
Rakuaria Pharmaceutical Co., Ltd. es una empresa centrada en la investigación y el desarrollo de nuevos fármacos. Se especializa en tratamientos innovadores en el sector de la salud y farmacéutico.